Biopharma News

Dec 12, 2014
BioPharm International
Reference product manufacturers and trade groups support automatic medication switches in new biosimilar “compromise” terms.
Dec 11, 2014
BioPharm International
By BioPharm International Editors
US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.
Dec 09, 2014
BioPharm International
By BioPharm International Editors
On December 8, Pfizer announced that it will establish a research program in gene therapy, and collaborate with Spark Therapeutics in Philadelphia, to develop potential gene therapy treatments for hemophilia.
Dec 08, 2014
BioPharm International
Sandoz announces their version of filgrastim, a follow-on biologic for the treatment of neutropenia, is as safe and effective as Amgen's Neupogen.
Dec 08, 2014
BioPharm International
The acquisition will enhance Merck's "superbug" medication portfolio.
Dec 08, 2014
By BioPharm International Editors
Under an NIH contract, Paragon Bioservices will design a manufacturing process for recombinant human rhE-selectin protein.
Dec 04, 2014
BioPharm International
Amgen's bispecific T-cell engager (BiTE) antibody constructs help the body fight malignant cancer cells.
Dec 04, 2014
BioPharm International
Sanofi executives are being charged in a whistleblower lawsuit for allegedly granting illicit payments to healthcare providers.
Dec 03, 2014
BioPharm International
CytRx receives formal written communication from FDA on a prior decision for a partial clinical hold for CytRx's trials involving chemotherapeutic agent aldoxorubicin.
Dec 02, 2014
BioPharm International
By BioPharm International Editors
Roche announced the acquisition of Ariosa Diagnostics, a molecular diagnostics testing service provider and maker of the prenatal blood test, Harmony.
native1_300x100
lorem ipsum